Canada markets closed

Travere Therapeutics, Inc. (TVTX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
8.22-0.06 (-0.72%)
At close: 04:00PM EDT
8.55 +0.33 (+4.01%)
After hours: 04:35PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 625.78M
Enterprise Value 588.75M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)4.04
Price/Book (mrq)8.45
Enterprise Value/Revenue 3.78
Enterprise Value/EBITDA -5.60

Trading Information

Stock Price History

Beta (5Y Monthly) 0.78
52-Week Change 3-47.14%
S&P500 52-Week Change 322.55%
52 Week High 317.57
52 Week Low 35.12
50-Day Moving Average 36.74
200-Day Moving Average 37.68

Share Statistics

Avg Vol (3 month) 31.27M
Avg Vol (10 day) 31.69M
Shares Outstanding 576.13M
Implied Shares Outstanding 676.13M
Float 856.1M
% Held by Insiders 10.73%
% Held by Institutions 1119.02%
Shares Short (Jun 14, 2024) 413.41M
Short Ratio (Jun 14, 2024) 413.87
Short % of Float (Jun 14, 2024) 419.83%
Short % of Shares Outstanding (Jun 14, 2024) 417.62%
Shares Short (prior month May 15, 2024) 413.44M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin -103.47%
Operating Margin (ttm)-335.91%

Management Effectiveness

Return on Assets (ttm)-35.53%
Return on Equity (ttm)-315.89%

Income Statement

Revenue (ttm)155.72M
Revenue Per Share (ttm)2.04
Quarterly Revenue Growth (yoy)33.90%
Gross Profit (ttm)N/A
EBITDA -376.56M
Net Income Avi to Common (ttm)-415.73M
Diluted EPS (ttm)-5.41
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)441.04M
Total Cash Per Share (mrq)5.79
Total Debt (mrq)404.02M
Total Debt/Equity (mrq)545.44%
Current Ratio (mrq)2.78
Book Value Per Share (mrq)0.97

Cash Flow Statement

Operating Cash Flow (ttm)-317.91M
Levered Free Cash Flow (ttm)-159.79M